Mischley et al. has published a new paper with a goal to identify a signature of bioenergetic and functional markers in the muscles of individuals with Parkinson’s disease (PD). The study shows that the mitochondrial dysfunction (low NAD+ and ATP) is associated with worse PD Symptoms. This is especially exciting in light of the NADPARK /NOPARK studies, currently attempting to boost NAD+ and ATP.